Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04406467 · ClinicalTrials.gov registry record
Retrospective Review of Xen Gel Stent Implantation With Open vs. Closed Conjunctiva Approach
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 137
- Enrollment target
NCT04406467: Completed study, sponsored by Johns Hopkins University.
NCT04406467 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 137 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04406467 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 137 participants
- Enrollment target
Study Summary
To measure surgical success of open vs closed conjunctiva with Xen implantation.
Primary Outcome
This will be assessed as the proportion of patients that will need fibrosis relief by stent re-implantation
Interventions
- DEVICE Xen Gel Stent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2017-11-19 |
| Est. Completion | 2020-08-26 |
What the finished NCT04406467 record still lists
NCT04406467 is an observational study that tracks outcomes without assigning an intervention. The registered 137 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Xen Gel Stent is the first listed.
NCT04406467 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04406467 about?
NCT04406467 is a clinical study titled "Retrospective Review of Xen Gel Stent Implantation With Open vs. Closed Conjunctiva Approach". To measure surgical success of open vs closed conjunctiva with Xen implantation.
What is the current status of trial NCT04406467?
This trial is currently completed. The enrollment target is 137 participants. The study started on 2017-11-19. Estimated completion is 2020-08-26.
What interventions are being tested in trial NCT04406467?
The interventions under investigation include: Xen Gel Stent (DEVICE).
Who is sponsoring clinical trial NCT04406467?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05091424 · 137 participants · Phase 1
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
- NCT05655182 · 137 participants · Phase 1
A Study of BLB-201 RSV Vaccine in Infants and Children
- NCT06571669 · 137 participants · NA
BOOM-IBD2 Pivotal Clinical Trial
- NCT06644768 · 137 participants · Phase 1
A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI